| Age (years), mean (±SD) |
|
| Male | 68.7 (8.82) |
| Female | 69.7 (7.27) |
| Sex, n (%) |
|
| Male | 102 (53%)* |
| Female | 89 (47%) |
| Disease duration (years), median (min-max) |
|
| Male | 7 (1 - 28) |
| Female | 8 (1 - 21) |
| Missing | n = 1 |
| Walking aid, n (%) |
|
| None | 145 (75.9%) |
| Walking sticks | 4 (2.1%) |
| Crutches | 2 (1.0%) |
| Walker | 36 (18.8%) |
| Mobility scooter | 1 (0.5%) |
| Combination | 3 (1.6%) |
| Levodopa equivalent dose (mg), median (min-max) | 700 (0 - 2100) |
| Male | 800 (0 - 2100) |
| Female | 650 (100 - 1350) |
| Use of other anti-Parkinson medication, n (%) |
|
| No extra drugs | 60 (31.4%) |
| 1 extra drug | 97 (50.8%) |
| 2 extra drugs | 31 (16.2%) |
| 3 extra drugs | 2 (1.0%) |
| 4 extra drugs | 1 (0.5%) |